EGF and hepatocellular carcinoma: In addition, catechol decreased the activation of MMP-2 and phosphorylation of EGFR, AKT, and ERK in EGF-treated HCC cells treated with EGF and these results indicate that catechol could migrate and invade by modulating the activity of MMP-2 through the EGFR signaling pathway.